Latest News

• share
• favorite_border

A team of artificial intelligence researchers developed a new deep-learning method to identify tumours in medical images.

• share
• favorite_border

A diet high in saturated fat causes, in addition to obesity and metabolic changes associated with a prediabetic state, anxiodepressive and compulsive behaviors. All of these effects were shown to be tied to inflammation in the nucleus accumbens, revealed a study conducted by a team from the CHUM Research Center (CRCHUM).

• share
• favorite_border

The Centre hospitalier de l’Université de Montréal (CHUM) is now offering a new surgical treatment for patients with lymphedema, swelling caused by the abnormal accumulation of lymph fluid in a body part, most often the arms or legs. Lymphovenous bypass surgery consists of microsurgically connecting the affected lymphatic vessels to the venous system to facilitate lymph fluid flow, decrease the severity of the lymphedema, reduce the complications related to this chronic disease and improve the quality of life of lymphedema patients.

• share
• favorite_border

Researchers at the University of Montreal Hospital Research Centre (CRCHUM) have identified a promising solution to improving treatments offered to patients with cystic fibrosis.

• share
• favorite_border

Canadian researchers discovered that pimozide, a drug used to treat schizophrenia, has the potential to slow the progression of amyotrophic lateral sclerosis (ALS). A clinical trial must confirm the efficacy and safety of the drug before it is offered to patients.

• share
• favorite_border

With $1 million in funding from the Canadian Institutes of Health Research, PAROLE-Onco will integrate patient-partners into the health care teams of the oncology departments of six Quebec health institutions. This is the first research project of its kind to evaluate the effects of integrating patient-partners into health care teams.

• share
• favorite_border

Patients with common widespread forms of cancer will enjoy longer life expectancy and reduced risk of recurrence thanks to a multimodal optical spectroscopy probe developed by ingeneer Frédéric Leblond and neurosurgical oncology specialist Dr. Kevin Petrecca.

• share
• favorite_border

An experimental treatment in mice allows the reprogramming of blood cells in order to promote the healing process of cutaneous wounds. This novel approach published recently in Journal of Investigative Dermatology could prove to be beneficial in healing challenging wounds in diabetics and major-burn victims.